item management s discussion and analysis of financial condition and results of operations liquidity and capital resources the company s primary source of liquidity is cash provided from operating activities  million in fiscal and million in fiscal cash and short term investments totaled and million and working capital was and million at june  and  respectively 
in addition  the company s long term investments totaled and million for the same periods 
these investments are highly liquid and can be used for working capital if needed 
the company has sufficient lines of credit available with banks  should any additional funds be required 
certain components of working capital had significant changes 
inventory increased million to million at june  from million at june  the primary reasons for this increase were the acquisition of schweizerhall inc schweizerhall in january which added over million in inventory and a higher inventory level in our organic intermediates and colorant segment due to increasing sales 
the decrease of million in cash and short term investments was the result of the following initiatives the company continued its stock repurchase program and purchased  shares of common stock for million 
it also acquired certain assets of schweizerhall which required an initial cash outlay of million and certain assets of magnum research corp 
magnum which required an initial outlay of million 
additional cash needed for the above mentioned initiatives caused a decrease in long term investments of million 
the total of drafts and acceptances payable  accounts payable and accrued merchandise purchases increased by million from million to million primarily due to the impact of the previously mentioned acquisitions 
any funds required for additional acquisitions  stock buybacks  or environmental remediation will be funded by the aforementioned sources of liquidity 
results of operations net sales by segment segment of of of total million total million total million agrochemicals industrial chemicals organic intermediates colorants pharmaceutical biochemicals nutritionals pharmaceutical intermediates custom mfg 
institutional sanitary supplies other total net sales gross profit by segment segment of of of million total million total million total agrochemicals industrial chemicals organic intermediates colorants pharmaceutical biochemicals nutritionals pharmaceutical intermediates custom mfg 
institutional sanitary supplies other total gross profit sales and gross profit in fiscal vs 
net sales increased 
the acquisition of the distribution business of schweizerhall  completed in january  accounted for a majority of the increase in the pharmaceutical biochemicals and nutritionals segment and a smaller portion of the increase in the industrial chemicals segment 
the remainder of the industrial chemicals increase was from a general strengthening of demand across its product lines 
the increase in sales of the organic intermediates and colorants segment was due to a general rebound in demand from the very depressed levels of  coupled with new sales of agricultural intermediates 
on the other hand  the pharmaceutical intermediates and custom manufacturing segment declined  reflecting lower sales of one significant product which accounted for over of sales of this segment in and in in fiscal  we do not anticipate that there will be any sales of this product 
the inclusion in the results for a full year of cdc products corp 
cdc and  for nine months  magnum  both acquisitions in the institutional sanitary supplies and other segment  accounted for that segment s increase 
gross profit by segment for the entire corporation increased 
the industrial chemicals  organic intermediates and colorants  and pharmaceutical biochemicals and nutritionals segments all showed higher percentage increases in gross profit than sales 
generally  this was the result of a corporate focus on improved sourcing  especially from china 
also  the growth of the institutional sanitary supplies and other segment contributed  as these products have significantly higher gross profit percentages 
in fiscal vs 
net sales decreased 
the agrochemicals and organic intermediates and colorants segments showed the largest changes 
the agrochemicals segment suffered the loss of two very low profit products 
continued erosion in selling prices was the main factor in the sales decrease in the organic intermediates and colorants segment 
the pharmaceutical intermediates and custom manufacturing segment increased because of increased sales of several relatively new products 
the loss of sales of one biochemical accounted for most of the decrease in the pharmaceutical biochemicals and nutritionals segment 
lastly  the acquisition of cdc was the cause of the increase in the institutional sanitary supplies and other segment 
total gross profit by segment  corporatewide  decreased only slightly 
the organic intermediates and colorants segment showed the largest decrease  and this was in line with the sales decrease 
the aforementioned loss of sales in the agrochemicals segment had virtually no impact on gross profit 
several segments showed slight decreases or increases and the cumulative effect of these segments was offset by the increase in institutional sanitary supplies and other from the cdc acquisition 
selling  general and administrative expense selling  general and administrative expenses increased by million to million in fiscal compared to million in fiscal the inclusion of cdc and magnum in the consolidated financial statements accounted for million of this increase 
additional costs relating to the schweizerhall acquisition accounted for a large portion of the remaining increase 
compensation expense and fringe benefits increased due to routine annual increases 
selling expenses increased due to our expanding china office and expenses relating to the increase in personnel from our recent acquisitions 
bank charges increased significantly due to an informal compensating balance agreement 
a significant increase in legal fees was due to an ongoing arbitration with the former owner of cdc 
offsetting some of these increases was a decrease in bad debt expense 
selling  general and administrative expenses increased by million to million from million in fiscal compared to the inclusion of cdc in the consolidated financial statements accounted for  of this increase 
a customer claim in the amount of  was recorded in march compensation increased by  due to payments of bonuses  annual salary increases and additional personnel 
in addition  there were increases in legal fees  bad debts and fringe benefits 
offsetting some of these increases were decreases in bank charges  selling expenses and consulting fees 
interest expense and other income interest expense was   and  in fiscal  and  respectively 
a twelve year note  payable to the prudential insurance company of america  was paid in full in december interest and other income decreased by million to million in fiscal compared to million in fiscal lower cash available for investments during the fiscal year due to the company s continuing stock repurchase program  along with the aforementioned acquisitions  caused a significant decrease in interest income on investments 
in addition  a loss on marketable securities in fiscal compared to a gain in fiscal  accounted for  of this decrease 
royalty income decreased  in comparing these two periods due to a decrease in sales of an agricultural product sold in europe 
interest and other income increased slightly in fiscal compared to higher average cash available for investments during the fiscal year resulted in a slight increase in investment income 
royalty income increased significantly due to increased sales of an agricultural product in europe 
offsetting most of these increases was a decrease in proceeds from the sale of inventory relating to a subsidiary sold in june also  gains on marketable securities decreased in fiscal compared to tax rates the effective tax rates were  and in fiscal  and  respectively 
significant payments from the company s non qualified retirement plan  which are deductible for tax purposes on the date of distribution  caused an unusually low tax rate for the year ended june  impact of new accounting pronouncements in june and june  respectively  the financial accounting standards board fasb issued statement of financial accounting standards sfas no 
 accounting for derivative instruments and hedging activities deferral of the effective date of fasb statement no 
and sfas no 
 accounting for certain derivative instruments and certain hedging activities 
sfas and amend sfas  accounting for derivative instruments and hedging activities  which was issued in june sfas deferred the effective date of sfas to all fiscal quarters of fiscal years beginning after june  sfas establishes accounting and reporting standards for derivative instruments  including certain derivative instruments embedded in other contracts and for hedging activities 
it requires that an entity recognize all derivatives as either assets or liabilities in the statement of financial position and measures those instruments at fair value 
the impact of the adoption of this new standard will not be material 
in march  the fasb issued fasb interpretation no 
fin accounting for certain transactions involving stock compensation an interpretation of accounting principles board opinion no 
opinion 
this interpretation clarifies the application of opinion for certain issues 
with certain exceptions  fin applies prospectively to new awards  exchanges of awards in a business combination  modifications to outstanding awards and changes in grantee status on or after july  the impact of this interpretation is not expected to be material 
market risk the company maintains foreign currency contracts solely to hedge open purchase commitments 
it has established policies  procedures and internal processes governing the management of this hedging to reduce market risks inherent in foreign exchange 
also  the company has interest rate exposure relating to short and long term investments and minimal exposure in the equity markets 
any change in these markets would not materially affect the consolidated financial position  results of operations or cash flows of the company 
forward looking statements this annual report on form k contains forward looking statements relating to such matters as anticipated financial performance and business prospects 
when used in this annual report  the words anticipates  expects  may  intend and similar expressions are intended to be among the statements that identify forward looking statements 
from time to time  the company may also publish forward looking statements 
the private securities litigation reform act of provides a safe harbor for forward looking statements 
in order to comply with the terms of the safe harbor  the company notes that a variety of factors  including  but not limited to  foreign currency risks  political instability  changes in foreign laws  regulations and tariffs  new technologies  competition  customer and vendor relationships  seasonality  inventory obsolescence and inventory availability  could cause the company s actual results and experience to differ materially from the anticipated results or other expectations expressed in the company s forward looking statements 

